医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Hoya Reports Fourth Quarter Results; Achieves Record Annual Sales and Profit

2016年05月09日 PM08:01
このエントリーをはてなブックマークに追加


 

TOKYO

HOYA Corporation (TOKYO:7741) today announced financial results for the fourth quarter and full-year ended March 31, 2016. During the quarter, revenues decreased by 4.5% to 121,666 million yen year on year. Pre-tax profit for the quarter was 23,161 million yen, while profit for the quarter was 18,493 million yen, both of which showed a decline of 8.5% and 0.1%, respectively, due partially to the reporting of 3,100 million yen in foreign exchange losses.

In the Information Technology segment, sales of LCD related products for smartphones and TVs rose year on year, however, sales of the semiconductor related products and glass substrates for HDDs were below the previous year. In the Life Care segment, although sales of the eye glass lenses business expanded in overseas markets, revenues were slightly below the previous year because of the impact of foreign currency fluctuations. Sales of medical endoscopes were weak, but sales of intraocular lenses business showed substantially higher sales above the previous year.

For the fiscal year ended March 31, 2016, revenues totaled 505,714 million yen, up 3.2% year on year. Pre-tax profit was 119,099 million yen and profit for the term was 93,317 million yen, a slight increase of 0.7% and 0.4% respectively year on year.

“We are taking necessary measures to generate profit even in shrinking markets of the Information Technology segment,” said Hiroshi Suzuki, chief executive officer of HOYA. “As for the Life Care segment, eye glass lenses business in Asia and endoscopes business in North America were dragging on overall performance, but these are expected to improve this year, and contribute to the group’s growth.”

HOYA also announced year-end dividends forecast of 45 yen per share. The annual dividends, including the interim dividends of 30 yen per share, will amount to 75 yen per share.

Summary of Consolidated Financial Statement

(Millions of Yen: Rounded to the nearest million)
  Three months ended   Variance   Full year ended   Variance
  Mar./15   Mar./16 (%) Mar./15   Mar./16 (%)
Revenue from all operations 127,440 121,666 -4.5 489,961 505,714 3.2
Profit before tax 25,309 23,161 -8.5 118,249 119,099 0.7
Profit for the term 18,513 18,493 -0.1 92,941 93,317 0.4
Basic earnings per share (yen)   44.72   46.56     218.23   225.45  

*Results are preliminary and unaudited.

 

The full reports are available at http://www.hoya.com

About HOYA
Founded in 1941 in Tokyo, Japan, Hoya is a global med-tech company and the leading supplier of innovative high-tech and medical products. Hoya is active in the fields of healthcare and information technology providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses as well as key components for semiconductor devices, LCD panels and HDDs. With over 150 offices and subsidiaries worldwide, Hoya currently employs a multinational workforce of over 34,000 people. For more information, please visit http://www.hoya.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160509005728/en/

CONTACT

Hoya Group
Akiko Chiba, +81-3-6911-4824
Public Relations
HOYA-pr@hoya.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in Esophageal Squamous Cell Cancer (ESCC) In China
  • AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China
  • STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement
  • 新研究调查诊断性多通道睡眠检查之前采用Masimo SET®脉搏氧饱和度仪居家监测筛查唐氏综合征患儿罹患阻塞性睡眠呼吸暂停的风险
  • ダウン症候群の小児を対象とする睡眠時障害診断のマルチチャンネル研究に先立つ閉塞性睡眠時無呼吸症リスクのスクリーニングとしてMasimo SET®パルスオキシメトリーを使用するホームモニタリングの有用性を検討する新研究